Details of the Drug Reposition

General Information of This Drug (ID: DMM7Z6K)

Drug Name
CXA10   DMM7Z6K
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pulmonary arterial hypertension DISP8ZX5 BB01.0 Phase 2 [1]
Focal segmental glomerulosclerosis DISJNHH0 MF8Y Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04053543) CXA-10 Study in Subjects With Pulmonary Arterial Hypertension. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03422510) FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS). U.S. National Institutes of Health.